Jordana Joy, Associate Editor

The Vision Lab Choice Act of 2025, S 1716 was introduced to the US Senate floor on May 12.

Researchers hypothesize that lamivudine was effective in the clinical trial against DME because the drug blocks the activity of inflammasomes.

The ophthalmology platform Optegra operates more than 70 eye hospitals and diagnostic facilities in 5 European markets.

CLARUS 700, the advanced retinal imaging system, captures 133 degrees in a single image and up to 267 degrees with multiple images.

The device was developed by Curators’ Distinguished Teaching Professor Carl Bassi and research collaborators Michael Howe and Wayne Garver of the University of Missouri – St Louis.

Catch up on the top stories in optometry during the week of June 2-June 6.

Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.

Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.

Both preservative-free, contact lens-friendly drops will be available in most national retailers.

Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.

Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.

Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.

A recent US Court of International Trade decision was made on May 28 to permanently prohibit all tariffs imposed by President Donald J. Trump under the International Emergency Economic Powers Act.

Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.

Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.

Catch up on the top stories in optometry during the week of May 26-May 30.

Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.

The partnership aims to accelerate Pangaea’s efforts to address critical care gaps in eye health and systemic disease.

Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, details the key takeaways from a poster presentation she participated in during ARVO 2025.

deepeye TPS is designed to close the gap between real-world outcomes and trial data by reducing patient dropout.

Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, discussed research that utilized IQVIA longitudinal prescription claims data from September through November 2023, coinciding with Miebo's FDA approval in September.

Researchers included 98 phase 2-4 uveitis trials during the time period from clinicaltrials.gov.

Steven Greenstein, MD, one of the cochairs of the Collaborative Care Symposium gave some insight into the upcoming conference and what attendees can expect.

The LMDD Eye Health Scorecard specifically evaluated insurance coverage for treatments addressing GA, neovascular AMD, and thyroid eye disease.

Catch up on the top stories in optometry during the week of May 19-May 23.

Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.

The novel intraocular lens works to restore dynamic range of vision following cataract surgery.

The OTC eye drops contain low-dose brimonidine tartrate 0.025%.

The drop has the potential to become the first-ever ocular surface indication for an IG.

The cross sector initiative that intends to drive a shift from reactive to proactive health care by leveraging ocular data through the means of oculomics.